Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-005125)

Filing Details

Accession Number:: 0001209191-18-005125
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-01-24 16:30:35
Reporting Period:: 2018-01-22

Accepted Time:: 2018-01-24 16:30:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401667	Puma Biotechnology Inc.	PBYI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1358285	H Alan Auerbach	C/O Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles CA 90024	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-01-22	10,692	$92.75	4,155,931	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2016 to satisfy tax obligations in connection with the vesting of restricted stock units.